Scarring/arrhythmogenic cardiomyopathy
暂无分享,去创建一个
D. Corrado | S. Rizzo | G. Thiene | C. Basso | M. Perazzolo Marra | A. Zorzi | B. Bauce | I. Rigato | F. Migliore | A. Cipriani | K. Pilichou | F. Graziano | M. De Lazzari | G. Brunetti | G. Mattesi | R. Bariani
[1] M. Link,et al. Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice? , 2022, European heart journal.
[2] D. Corrado,et al. Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy , 2021, Journal of the American Heart Association.
[3] D. Corrado,et al. Arrhythmogenic left ventricular cardiomyopathy , 2021, Heart.
[4] B. Giorgi,et al. ‘Hot phase’ clinical presentation in arrhythmogenic cardiomyopathy , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[5] A. Mazzanti,et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. , 2020, International journal of cardiology.
[6] D. Corrado,et al. Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy , 2020, Journal of the American Heart Association.
[7] M. Link,et al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis , 2019, European heart journal.
[8] A. Abidov,et al. Arrhythmogenic cardiomyopathy , 2018, The EACVI Textbook of Cardiovascular Magnetic Resonance.
[9] R. Weintraub,et al. Dilated cardiomyopathy , 2017, The Lancet.
[10] M. Link,et al. Arrhythmogenic Right Ventricular Cardiomyopathy. , 2017, The New England journal of medicine.
[11] S. Heymans,et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. , 2016, European heart journal.
[12] D. Corrado,et al. Arrhythmogenic Cardiomyopathy. , 2021, Circulation research.
[13] M. Link,et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement , 2015, European heart journal.
[14] D. Corrado,et al. Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia , 2010, Heart.
[15] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.
[16] A. Moorman,et al. Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy , 2009, The Journal of experimental medicine.
[17] D. Corrado,et al. Essay: Sudden death in young athletes , 2005, The Lancet.
[18] M. Davies,et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.
[19] A. Angelini,et al. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? , 1996, Circulation.
[20] D. Corrado,et al. Right ventricular cardiomyopathy: is there evidence of an inflammatory aetiology? , 1991, European heart journal.